1. International multicentre observational study to assess the efficacy and safety of a 0·5 mg kg−1 per day starting dose of oral corticosteroids to treat bullous pemphigoid. (1st December 2021) Authors: Hébert, V.; Bastos, S.; Drenovska, K.; Meijer, J.; Ingen‐Housz‐Oro, S.; Bedane, C.; Lunardon, L.; Debarbieux, S.; Jedlickova, H.; Caux, F.; Chaby, G.; D'Incan, M.; Feliciani, C.; Boulard, C.; Schumacher, N.; Schmidt, E.; Roussel, A.; Richard, M.A.; Gottlieb, J.; Ferranti, V. Journal: British journal of dermatology Issue: Volume 185:Number 6(2021) Page Start: 1232 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. International multicentre observational study to assess the efficacy and safety of a 0·5 mg kg−1 per day starting dose of oral corticosteroids to treat bullous pemphigoid. (2nd September 2021) Authors: Hébert, V.; Bastos, S.; Drenovska, K.; Meijer, J.; Ingen‐Housz‐Oro, S.; Bedane, C.; Lunardon, L.; Debarbieux, S.; Jedlickova, H.; Caux, F.; Chaby, G.; D'Incan, M.; Feliciani, C.; Boulard, C.; Schumacher, N.; Schmidt, E.; Roussel, A.; Richard, M.A.; Gottlieb, J.; Ferranti, V. Journal: British journal of dermatology Issue: Volume 185:Number 6(2021) Page Start: 1232 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗